Camilia Rivera Martin, MD

Highlights

1
Seminars in perinatology · 2023
AHAndrea Heras ZSZenna Solomon LKLauren K. Blatt CRCamilia Rivera Martin
PMID: 37775366DOISenior author12 citations
2
Nutrients · 2022
CRCamilia Rivera Martin
PMID: 35745141PMCID: PMC9230097DOISenior author17 citations
3
NeoReviews · 2022
CRCamilia Rivera Martin
PMID: 35102382DOISenior author15 citations

Publications

154

Funding

14 View NIH portfolio on RePORTER ↗

Active

12 grants

Co-I
Antenatal Anxiety and Dyadic Immune Risk(ADIR Study)
Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023–2029
R01HD110419-01
PI
Dr. Camilia Martin / Beth Israel Deaconess Medical Center Service Agreement
Beth Israel Deaconess Medical Center, Inc. · 2024–2029Contract
No publications yet
BIDMC 2400923-01
Sub-PI
Nutritional and clinical predictors of intestinal maturation and feeding tolerance in the preterm infant
Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023–2028 · via University of Illinois at Urbana-Champaign
R01HD112396-04
Sub-PI
Liver-Gut-Microbiome Axis in Preterm Neonates with Growth Failure
National Institute of Diabetes and Digestive and Kidney Diseases · 2023–2028 · via Baylor College of Medicine
R01DK135602-04
KP
America's SHIELD: Strategic Herpesvirus Immune Evasion and Latency Defense, through an AI/ML toolkit for broad genus-level immunity to chronic disease and cancer
Advanced Research Projects Agency for Health · 2024–2027 · via La Jolla Institute
No publications yet
AY1AX000055-01
PI
CMV+ milk: morbidity risk & translational potential of neutralizing antibodies
Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2024–2027
R21HD115905-02
Sub-PI
Reprogramming intestinal immunity in preterm neonates to prevent and cure necrotizing enterocolitis
National Institute of Diabetes and Digestive and Kidney Diseases · 2024–2027 · via University of North Carolina at Chapel Hill
DP1DK140012-03
Sub-PI
Phenotypic Driven Growth Trajectories in Very Preterm Infants to Define Nutrition
Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2022–2027 · via Yale University
R01HD106359-05
PI
Metabolic mechanisms induced by enteral DHA and ARA supplementation in preterm infants
Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2022–2027
R01HD108646-05
Co-I
Research Collaboration Agreement with Kamada Ltd.
Kamada Ltd. · 2026–2026BioPharma Alliance
BP 261022-01
Sub-PI
Integrating Patients to Accelerate the Science Towards a World Without NEC
Chan Zuckerberg Initiative · 2022–2026 · via University of North Carolina at Chapel Hill
UNC 2022-316749
Sub-PI
NICU Nutrition Collaborative (NNC)
Mead Johnson · 2022–2026 · via Beth Israel Deaconess Medical Center, Inc.
No publications yet
BIDMC 226795-01

Completed grants (2)

MPI
Maternal and Social Determinants of the Preterm Human Breast Milk Lipidome
American Academy of Pediatrics · 2024–2025
AAP 245218-01
PI
Impact of fatty acid imbalance in intestinal health and disease in prematurity
NIDDK · 2014–2019 · via NIH RePORTER
R01DK104346-04

Clinical research

Active

7 studies

PI
Reprogramming intestinal immunity in preterm neonates to prevent and cure necrotizing enterocolitis
University of North Carolina at Chapel Hill · OPEN TO ACCRUAL (as of 2025)
PI
Effect of nutritional intervention in preterm infants considered to be at high nutritional risk at birth
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
PI
Maternal and Social Determinants of the Preterm Human Breast Milk Lipidome
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2024)
PI
Integrating Patients to Accelerate the Science Towards a World Without NEC
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2024)
PI
Perinatal Intergenerational Research Institute Sample Biorepository
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2023)
PI
NICU Biorepository
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2023)
PI
Metabolic Mechanisms Induced by Enteral Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) Supplementation in Preterm Infants
NA · University of Texas Health Science Center at San Antonio · OPEN TO ACCRUAL (as of 2023)
Premature
NCT05380401

Completed & closed trials (1)

PI
Phenotypic Driven Growth Trajectories in Very Preterm Infants to Define Nutritionally Mediated Health Outcomes and Modifiable Targets
Beth Israel Deaconess Medical Center, Inc. · CLOSED TO ACCRUAL (as of 2025)

Mentoring

NW
Nicole Weitzel
MD mentee · Class of 2026

External relationships

Advisory/Scientific Board Member

LactaLogics, Inc. · Plakous Therapeutics LLC · Vitara Biomedical, Inc.

Professional Services

Wolters Kluwer Health, Inc.

Speaker/Lecturer

Baxter Healthcare Corporation · Mead Johnson

Other

Baxter Healthcare Corporation · Infant Bacterial Therapeutics AB (IBT) · Winston & Strawn LLP